[go: up one dir, main page]

AU1671197A - Vaccine-containing emulsion and vaccine-containing powder for oral administration and process for producing the same - Google Patents

Vaccine-containing emulsion and vaccine-containing powder for oral administration and process for producing the same

Info

Publication number
AU1671197A
AU1671197A AU16711/97A AU1671197A AU1671197A AU 1671197 A AU1671197 A AU 1671197A AU 16711/97 A AU16711/97 A AU 16711/97A AU 1671197 A AU1671197 A AU 1671197A AU 1671197 A AU1671197 A AU 1671197A
Authority
AU
Australia
Prior art keywords
vaccine
producing
same
oral administration
emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16711/97A
Inventor
Kumiko Kurokawa
Katsuhiko Ooyama
Miho Sakurada
Masashi Umemura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Oillio Group Ltd
Original Assignee
Nisshin Oil Mills Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Oil Mills Ltd filed Critical Nisshin Oil Mills Ltd
Publication of AU1671197A publication Critical patent/AU1671197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU16711/97A 1996-02-13 1997-02-10 Vaccine-containing emulsion and vaccine-containing powder for oral administration and process for producing the same Abandoned AU1671197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8-25482 1996-02-13
JP2548296 1996-02-13
PCT/JP1997/000351 WO1997029773A1 (en) 1996-02-13 1997-02-10 Vaccine-containing emulsion and vaccine-containing powder for oral administration and process for producing the same

Publications (1)

Publication Number Publication Date
AU1671197A true AU1671197A (en) 1997-09-02

Family

ID=12167279

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16711/97A Abandoned AU1671197A (en) 1996-02-13 1997-02-10 Vaccine-containing emulsion and vaccine-containing powder for oral administration and process for producing the same

Country Status (2)

Country Link
AU (1) AU1671197A (en)
WO (1) WO1997029773A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
WO2004030608A2 (en) * 2001-06-05 2004-04-15 The Regents Of The University Of Michigan Nanoemulsion vaccines
JP4579156B2 (en) * 2002-11-01 2010-11-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Immunogenic composition
CN1218750C (en) 2003-06-06 2005-09-14 长春生物制品研究所 Recombinant Hepatitis B BCG Combined Vaccine for Intradermal Injection and Preparation Method
US9839685B2 (en) 2006-04-13 2017-12-12 The Regents Of The University Of Michigan Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
US10138279B2 (en) 2006-04-13 2018-11-27 Regents Of The University Of Michigan Compositions and methods for Bacillus anthracis vaccination
AU2009248810B2 (en) 2008-05-23 2013-12-05 The Regents Of The University Of Michigan Nanoemulsion vaccines
CN102223876A (en) 2008-09-26 2011-10-19 纳米生物公司 Nanoemulsion therapeutic compositions and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
JPH06507172A (en) * 1991-04-19 1994-08-11 アフィニティー　バイオテック，インコーポレイテッド Convertible microemulsion formulation
JPH05294845A (en) * 1991-11-25 1993-11-09 Nisshin Oil Mills Ltd:The Immunogen composition
AU5543294A (en) * 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants

Also Published As

Publication number Publication date
WO1997029773A1 (en) 1997-08-21

Similar Documents

Publication Publication Date Title
AU694647B2 (en) Acetamide derivatives, process for producing the same, and medicinal composition containing the same
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
AU5428096A (en) Oral 2-methyl-thieno-benzodiazepine formulation
HUP9901086A3 (en) Arylsulfonylaminobenzene derivatives, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
HUS1400001I1 (en) Quinazoline derivatives, producing them and pharmaceutical compositions containing the compounds
AUPN411195A0 (en) Medicinal composition
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
AU8627898A (en) Pyrimidin-2,4,6-trion derivatives, method for producing the same and medicinal products containing these compounds
EP0674834A3 (en) Pretzel and method for preparation of the same.
AU1671197A (en) Vaccine-containing emulsion and vaccine-containing powder for oral administration and process for producing the same
HUP0001551A3 (en) Improved method for producing thiazolidinediones, thiazolidinediones and pharmaceutical compositions containing the same
AU5101798A (en) Method for oral administration of buspirone
AU5401796A (en) Solid delivery form for oral use
AU5347996A (en) Preparation for oral administration
AU2171297A (en) Pharmaceutical compositions and methods for the manufacture thereof
AU1475595A (en) Pharmaceutical preparation
AU7711096A (en) Cisplatinum comprising pharmaceutical
GR3036226T3 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same
AU4613796A (en) Medicament in particle form
AU6194899A (en) Pharmaceutical preparation containing taxane and method for producing the same
AU8048598A (en) Powder composition and process for the preparation thereof
AU1557797A (en) 2,3-disubstituted cyclopentanone derivatives, process for producing the same, and medicinal use thereof
AU6252396A (en) Process for the preparation of tertiary aminocarbonates and aminoethers
HUP9901870A3 (en) 5alfa-reductase inhibitory preparation for oral administration, process for producing the same, and use thereof
AU2576295A (en) Solid antacid and process for producing the same